JSE-listed health and care brands company Ascendis Health has become the first healthcare company to list on A2X Markets, under the code\u00a0ASC.<\/p>\n
The group has a market cap of R5.4 billion.<\/p>\n
Ascendis will retain its primary listing on the JSE and its issued share capital will be unaffected by its secondary listing on A2X.<\/p>\n
“We see the secondary listing as an opportunity to attract potential new investors through the lower-cost trading structure of A2X and broaden our shareholder base. There is no cost to the secondary listing or any additional regulatory compliance,” said Ascendis Health CEO, Thomas Thomsen.<\/p>\n
A2X began trading in October last year and now has eight approved brokers and eight companies listed on its platform with a combined market capitalisation of more than R220 billion.<\/p>\n
A2X uses technology developed by the UK\u2019s Aquis Technologies, a division of Aquis Exchange, which includes proven exchange matching and surveillance systems and a clearing platform custom-built for A2X.<\/p>\n
Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority. The market-leading exchange systems are fast and efficient. Its surveillance system is programmed to monitor trading across multiple markets and ensures that any trading anomalies are detected early.<\/p>\n